SGLT2 Inhibitors Enhance Metallothionein Expression in Kidney Proximal Tubules of Adolescents With Type 2 Diabetes

被引：0

作者：

Alakwaa, Fadhl ^{[1
]}

McCown, Phillip J. ^{[1
]}

Naik, Abhijit S. ^{[1
]}

Schaub, Jennifer A. ^{[1
]}

Menon, Rajasree ^{[1
]}

Otto, Edgar A. ^{[1
]}

Nair, Viji ^{[1
]}

Eddy, Sean ^{[1
]}

Pyle, Laura ^{[4
]}

Harned, Roger K. ^{[4
]}

Ladd, Patricia E. ^{[4
]}

Eichinger, Felix H. ^{[1
]}

Fermin, Damian ^{[1
]}

Ju, Wenjun ^{[1
]}

Hodgin, Jeffrey B. ^{[1
]}

Nelson, Robert G. ^{[3
]}

Brosius, Frank C. ^{[2
]}

Kretzler, Matthias ^{[1
]}

Bjornstad, Petter ^{[4
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Univ Arizona, Tucson, AZ USA

[3] NIDDK, Phoenix, AZ USA

[4] Univ Colorado, Sch Med, Aurora, CO USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

TH-PO211

引用

页码：107 / 107

页数：1

共 50 条

[31] Are SGLT2 inhibitors joining the mainstream therapy for diabetes type 2?
Hassanabad, Mortaza E.
Abad, Zahra F. H.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 1893 - 1896
[32] Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
Nauck, Michael A.
DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1335 - 1380
[33] The effects of SGLT2 inhibitors on corneal neuroinflammation in type 2 diabetes
Asiedu, Kofi
Tummanapalli, Shyam
Alotaibi, Sultan
Wang, Leiao Leon
Dhanapalaratman, Roshan
Kwai, Natalie
Poynten, Ann
Krishnan, Arun
Markoulli, Maria
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
[34] Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus
Anna Solini
Acta Diabetologica, 2016, 53 : 863 - 870
[35] SGLT2 inhibitors in diabetes with CKD
Malik, A. H.
Yandrapalli, S.
Goldberg, M.
Jain, D.
Frishman, W. H.
Aronow, W. S.
EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
[36] Cardiorenal Protections of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes
Nazari, Somayeh
Mirkhani, Hossein
CURRENT DIABETES REVIEWS, 2023, 19 (08)
[37] SGLT2 inhibitors and autophagy in diabetes
Yaribeygi, Habib
Maleki, Mina
Atkin, Stephen L.
Jamialahmadi, Tannaz
Sahebkar, Amirhossein
CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (04) : 392 - 398
[38] Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
Scheen, Andre J.
Delanaye, Pierre
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (01) : 35 - 46
[39] Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
Scheen, Andre J.
EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 243 - 256
[40] Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors Shifting the Goalposts Upstream
Rangaswami, Janani
Mathew, Roy O.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (09): : 1119 - 1121

← 1 2 3 4 5 →